Main > ONCOLOGY (**) > Kidney Cancer>RCC>MET *** > Treatment > USA. P. Sunitinib ***

---

USA. P. Sunitinib ***'s subsections
(*) JP Approval Date: ?
(*) USA Approval Date: 2006. 01.26
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2007. 01.23
Patent>US Expiration: 2021. 02.15
TradeMark
TradeMark Web-Site

USA. P. Sunitinib ***'s products
This section has no products